Clinical Trial Coordinator
Helen joined EnGeneIC in March 2015 as Clinical Trial Coordinator. Helen has worked within the field of clinical research for more than 20 years, developing expertise in the management and conduct of Phase I-IV oncology trials, from feasibility to close-out, in Industry and non-Industry environments.
Originating from the UK, Helen trained as an RGN at London’s St Bartholomew’s Hospital, gaining extensive clinical experience in haematological and solid tumour malignancies. She has worked with major pharmaceutical companies in both the UK and Australia, Rhône-Poulenc Rorer, (Sanofi)-Aventis and AstraZeneca, managing key registration studies for innovative oncology therapeutics.